Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Accepts NDA for First-Ever Digital Medication

September 15, 2015 8:25 am | by Ryan Bushey, Associate Editor | News | Comments

This creation could provide significant assistance in helping to treat behavioral health conditions. Read more...


New Ebola Death Reported in Sierra Leone

September 15, 2015 7:55 am | News | Comments

The announcement marked another setback in ending Ebola transmission in Sierra Leone. Read more...


Bringing Global Health Home

September 15, 2015 7:45 am | by Harvard Gazette | News | Comments

After 5 years, institute outlines recent successes, rising challenges that face everyone. Read more...


New Leukemia Gene Stops Blood Cells 'Growing Up'

September 15, 2015 7:41 am | by University of Manchester | News | Comments

The FOXC1 gene is normally switched on during embryonic development and is needed to turn cells into specialized tissues. Read more...


An Antibody that Can Attack HIV in New Ways

September 15, 2015 7:25 am | by Caltech | News | Comments

The process of HIV infection begins when the virus comes into contact with T cells that carry a particular protein on their surface. Read more...


Sanofi: Combination Diabetes Drug Reaches Target in Second Phase 3 Trial

September 14, 2015 12:36 pm | by Stephanie Guzowski, Editor | News | Comments

Sanofi announced on Monday a second Phase 3 study of its diabetes drug, LixiLan, met its main goal of reducing HbA1c compared with insulin glargine (Lantus) in people with Type 2 diabetes. Read more...


Raptor Pharma May Terminate Development of Liver Drug

September 14, 2015 12:34 pm | by Ryan Bushey, Associate Editor | News | Comments

Shares of the company plunged 35.5 percent in premarket trading today. Read more...


HIV Prevention Pill 100 Percent Effective in Trial, Researchers Say

September 14, 2015 10:51 am | by Seth Augenstein, Digital Reporter | News | Comments

An antiviral pill proved 100 percent effective in preventing new cases of HIV, according to a new Kaiser Permanente study. Truvada was administered to 657 sexually-active people over 32 months – and there were no new cases of HIV reported, according to the study, published in the journal Clinical Infectious Diseases this month. Read more...


A Biomarker Strategy for Hard-to-Treat Form of Lung Cancer

September 14, 2015 10:24 am | by Yale University | News | Comments

Analysis of a large Phase 3 trial (S0819) investigating the addition of a monoclonal antibody targeting the EGFR to chemotherapy in patients with non-small cell lung cancer (NSCLC) suggests that squamous cell lung cancer patients with tumors positive for the EGFR gene copy number (FISH) have a survival benefit, while non-squamous histology patients and those EGFR FISH-negative derive no survival advantage. Read more..


Heroin Epidemic Puts Pressure On Schools to Get Antidote

September 14, 2015 9:59 am | by Michelle R. Smith, Associated Press | News | Comments

The heroin epidemic that has been taking the lives of teenagers for years is creeping into even younger age groups and putting pressure on the nation's schools to keep a fast-acting overdose antidote within reach of every nurse and teacher. Read more...


FDA Advisers Vote Against Approving Purdue's Opioid Drug

September 14, 2015 8:47 am | by Ryan Bushey, Associate Editor | News | Comments

The vote was made over concerns related to dosing issues. Read more...


Wasp Venom May be Able to Safely Destroy Different Tumor Types

September 14, 2015 8:25 am | by Ryan Bushey, Associate Editor | News | Comments

A series of lab tests had shown the insect's venom was able to inhibit bladder and prostate cancer cells along with various forms of drug-resistant leukemia. Read more...


People Who Eat Junk Food Have Smaller Hippocampi, Australian Researchers Say

September 14, 2015 8:24 am | by Seth Augenstein, Digital Reporter | News | Comments

A person who eats more junk food has a smaller part of the brain used in emotion, memory and learning, says a first-of-its kind study from Australian scientists. Read more...


Mylan Says It Will Launch $27.14B Bid for Perrigo

September 14, 2015 8:15 am | by The Associated Press | News | Comments

Perrigo has already turned down several offers from Mylan. Read more...

Gencia, Takeda Team to Discover and Develop Mitochondrial Therapeutics

September 14, 2015 7:55 am | News | Comments

The initial aim of the collaboration will be joint research and development leading to two preclinical drug candidates. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.